Form 4: BioXcel Therapeutics CEO Vimal Mehta Reports Stock Transactions
SEC Form 4
BioXcel Therapeutics CEO Vimal Mehta reports the vesting and conversion of restricted stock units into common stock.
Summary
- On March 14, 2025, Vimal Mehta, CEO and President of BioXcel Therapeutics, Inc., reported transactions involving the company's stock.
- Mehta converted 162 Restricted Stock Units (RSUs) into common stock.
- Following this transaction, Mehta directly owns 3,887 shares of common stock and 1,142 RSUs.
- On March 15, 2025, Mehta converted 217 Restricted Stock Units (RSUs) into common stock.
- Following this transaction, Mehta directly owns 4,104 shares of common stock and 2,408 RSUs.
- Mehta also indirectly owns 125 shares of common stock through his spouse and 480,343 shares through BioXcel LLC.
- Mehta disclaims beneficial ownership of the securities held by BioXcel LLC except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions, so the sentiment is neutral.
Management Comments
- The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who have transactions in their company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/14/2022 | Reporting Person was granted 2,609 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter. |
| 03/15/2023 | Reporting Person was granted 3,500 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter. |
| 03/14/2025 | Vimal Mehta converted 162 Restricted Stock Units into common stock. |
| 03/15/2025 | Vimal Mehta converted 217 Restricted Stock Units into common stock. |
| 03/17/2025 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.